pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,162 catalysts · 4,876 phase readout · 2,346 8k filing · 286 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 16 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: earnings×type: recall×clear all
type
  • phase readout4,876
  • 8k filing2,346
  • earnings286
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05078905: Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: COVID-19, Vaccination, Healthy Volunteer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06456905: Automated Reinforcement Management Systems, Phase II

    Sponsor: Washington State University. Phase: NA. Conditions: Alcohol Use Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07444905: Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma

    Sponsor: Tongji Hospital. Phase: . Conditions: HCC - Hepatocellular Carcinoma, Machine Learning, Evaluation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07352605: Percutaneous Drainage Versus Antibiotic Therapy for Acute Diverticulitis With Abscess.

    Sponsor: Azienda Sanitaria di Firenze. Phase: NA. Conditions: Diverticular Disease of Colon

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07221266: Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

    Sponsor: University of Texas, El Paso. Phase: NA. Conditions: Parkinson Disease (PD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00455156: Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring

    Sponsor: Premier Research. Phase: PHASE3. Conditions: Contraception

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07511166: A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation

    Sponsor: Johnson & Johnson Medical (Shanghai) Ltd.. Phase: . Conditions: Atrial Fibrillation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05287256: Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC

    Sponsor: Johns Hopkins University. Phase: PHASE1. Conditions: Behavioral Pharmacology of Cannabis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05678322: Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

    Sponsor: NYU Langone Health. Phase: PHASE3. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07382622: Effect of JointIQ on Joint Discomfort in Healthy Subjects

    Sponsor: Chung Shan Medical University. Phase: NA. Conditions: Joint Discomfort

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07056322: Optimal Meals to Reduce Bone Resorption in Women With Osteopenia

    Sponsor: University of Aarhus. Phase: NA. Conditions: Osteopenia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07552220: Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography

    Sponsor: Centre Hospitalier de Mâcon. Phase: . Conditions: Myositis, Health Adult Subjects

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06635824: Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

    Sponsor: Genmab. Phase: PHASE3. Conditions: PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06373380: A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: EARLY_PHASE1. Conditions: HPV16+ Squamous Cell Carcinoma

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT06364280: Pediatric Prehospital Airway Resuscitation Trial

    Sponsor: Ohio State University. Phase: NA. Conditions: Heart Arrest, Out-Of-Hospital, Wounds and Injuries, Respiratory Insufficiency in Children, Child, Only, Critical Illness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07290296: Popliteus Muscle Release Versus Kinesio Taping

    Sponsor: Cairo University. Phase: NA. Conditions: Patellofemoral Pain Syndrome

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07612696: Impact of Electronic Cigarette Temperature and Solvent on Biomarkers

    Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Oxidative Stress, Tobacco Use, Electronic Cigarettes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04406662: Routine Evaluation of People Living With Cancer

    Sponsor: University of Edinburgh. Phase: . Conditions: Cachexia; Cancer, Advanced Cancer, Quality of Life

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07639762: Comparison of the Efficacy of Ultrasound-guided Supra-inguinal Fascia Iliaca and Lumbar Erector Spina Plan Block in Hip Fractures

    Sponsor: Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. Phase: . Conditions: Hip Fracture, Pain Management, Multimodal Analgesia, Peripheral Nerve Block, Lumbar Erector Spinae Plane Block, Suprainguinal Fasia Iliaca Block

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07108062: Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis

    Sponsor: Hungarian University of Sports Science. Phase: NA. Conditions: Enuresis Nocturnal, Urinary Incontinence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06295562: Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea

    Sponsor: China Medical University Hospital. Phase: PHASE4. Conditions: Obstructive Sleep Apnea of Adult

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07098962: KinesioTaping for Thoracic Drain Support

    Sponsor: Kastamonu University. Phase: PHASE2. Conditions: Primary Condition: Pain, Postoperative, Associated Conditions: Cardiac Surgical Procedures, Thoracic Surgery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01783288: Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening

    Sponsor: Vanderbilt University. Phase: NA. Conditions: Postural Tachycardia Syndrome

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07644403: Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.

    Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd. Phase: PHASE1. Conditions: Epithelial Cancer Patients

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07465627: Vessel Recoil in Specific CLTI Populations

    Sponsor: Medical University of Graz. Phase: . Conditions: Chronic Limb Threatening Ischemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06553027: To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

    Sponsor: Cerevance. Phase: PHASE3. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07541261: A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia

    Sponsor: Janssen Research & Development, LLC. Phase: . Conditions: Colitis, Ulcerative, Crohn Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06954961: A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer

    Sponsor: InventisBio Co., Ltd. Phase: PHASE3. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05617742: Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

    Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07316686: Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma

    Sponsor: Instituto do Cancer do Estado de São Paulo. Phase: PHASE1. Conditions: Prostate Cancer (Adenocarcinoma)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05176470: Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

    Sponsor: Richard Wu. Phase: PHASE1. Conditions: Locally Advanced Melanoma, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Stage IV Melanoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06285773: Recto-intercostal Fascial Plane Block and Pecto-intercostal Fascial Plane Block for Cardiac Surgery

    Sponsor: Medipol University. Phase: NA. Conditions: Cardiac Disease

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07298486: Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALS

    Sponsor: Nova Southeastern University. Phase: NA. Conditions: Amyotrophic Lateral Sclerosis (ALS)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07461870: The Mediterranean Diet Based on Local Foods for Obese Patients

    Sponsor: Indonesia University. Phase: NA. Conditions: Obese Subjects

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06714370: Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Nationwide Study

    Sponsor: Ono Pharmaceutical Co., Ltd.. Phase: . Conditions: Primary Central Nervous System Lymphoma (PCNSL)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07602270: Effects of Ketogenic Diet on Alcohol Intoxication

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Ketogenic Diet, Alcohol Drinking, Alcohol Use Disorder, Magnetic Resonance Imaging, Alcohol Intoxication

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06278883: Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase

    Sponsor: Duke University. Phase: NA. Conditions: Cardiovascular Diseases, Cancer, Liver Diseases, Hyperthermia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06603441: Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea

    Sponsor: Stanford University. Phase: . Conditions: Obstructive Sleep Apnea of Adult

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05091905: Patient-Titrated Automated Intermittent Boluses of Local Anesthetic vs. a Continuous Infusion Via a Perineural Catheter for Postoperative Analgesia

    Sponsor: University of California, San Diego. Phase: PHASE4. Conditions: Pain, Acute Postoperative, Trauma Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07423494: Personalized Antisense Oligonucleotide Therapy for A Single Patient With CHCHD10 ALS (nL18576)

    Sponsor: n-Lorem Foundation. Phase: PHASE1. Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05800366: A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

    Sponsor: Jennifer Crombie, MD. Phase: PHASE2. Conditions: Lymphoma, Lymphoma, Large B-Cell, Diffuse

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04838756: Mammography Screening With Artificial Intelligence (MASAI)

    Sponsor: Region Skane. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01793922: POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)

    Sponsor: KU Leuven. Phase: NA. Conditions: Achalasia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04555551: MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07357051: Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza

    Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd. Phase: PHASE3. Conditions: Respiratory Viral Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06539390: Impact of Sedation on Patient Satisfaction, Radiation Exposure, and Complications in Lumbar Transforaminal Epidural Steroid Injections: A Retrospective Cohort Study

    Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Pain, Chronic

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03388190: METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin

    Sponsor: University Hospital, Akershus. Phase: PHASE2. Conditions: Colorectal Cancer Metastatic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07606690: The Geniohyoid Muscle in Critical Illness

    Sponsor: Warrington Hospital. Phase: . Conditions: Mechanical Ventilation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07373418: Glucose Observation and Wearable Use for Prevention

    Sponsor: University of St.Gallen. Phase: . Conditions: Prevention

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06979518: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry

    Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Pulmonary Disease, Chronic Obstructive

    full page →ctgov ↗
    ← prev
    page 80 of 104
    next →